Valuation: Seegene, Inc.

Market Cap 1,370B 884M 774M 715M 667M 1.26B 83.62B 1.28B 8.57B 3.33B 41.26B 3.32B 3.25B 144B P/E 2026 *
16.8x
P/E 2027 * 14.3x
Enterprise Value 1,370B 884M 774M 715M 667M 1.26B 83.62B 1.28B 8.57B 3.33B 41.26B 3.32B 3.25B 144B EV / Sales 2026 *
2.58x
EV / Sales 2027 * 2.27x
Free-Float
59.55%
Yield 2026 *
3.7%
Yield 2027 * 4.01%
1 day-2.46%
1 week+9.80%
1 month-2.30%
3 months+35.93%
6 months+24.79%
Current year+24.79%
1 week 27,100
Extreme 27100
31,450
1 month 26,350
Extreme 26350
32,400
Current year 21,700
Extreme 21700
32,500
1 year 21,700
Extreme 21700
33,350
3 years 19,040
Extreme 19040
36,650
5 years 19,040
Extreme 19040
94,700
10 years 7,225
Extreme 7225
161,100
Manager TitleAgeSince
Chief Executive Officer 69 2010-09-16
Director of Finance/CFO 60 -
President 54 -
Director TitleAgeSince
Director/Board Member 69 2011-06-30
Chairman 79 -
Director/Board Member 74 -
Date Insider Type Main position Quantity % Market Cap.
24-05-29Sell

Executive/Senior Manager

4,201 0.0080%
24-05-29Sell

Executive/Senior Manager

191 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-2.46%+9.80%-10.27%+44.53% 910M
-2.43%+9.18%+117.28%+130.59% 4.8B
+0.23%+24.49%+84.12%+219.67% 3.42B
-2.34%-2.61%-29.56%-41.56% 2.03B
-1.19%-6.31%+141.86%-40.91% 1.88B
-2.66%+13.46%+45.85%+235.29% 1.51B
-2.35%+16.20%+158.92%-49.80% 943M
+6.50%+14.57%+24.77% - 506M
-1.37%-6.40%-38.87%-21.32% 474M
-9.74%-0.18% - - 224M
Average -1.78%+7.26%+54.90%+59.56% 1.67B
Weighted average by Cap. -1.55%+10.08%+76.58%+97.52%

Financials

2026 *2027 *
Net sales 531B 343M 300M 277M 258M 487M 32.41B 496M 3.32B 1.29B 15.99B 1.29B 1.26B 55.72B 603B 390M 341M 315M 294M 553M 36.83B 563M 3.78B 1.47B 18.18B 1.46B 1.43B 63.32B
Net income 92.2B 59.54M 52.11M 48.11M 44.87M 84.55M 5.63B 86.06M 577M 224M 2.78B 224M 219M 9.68B 108B 69.93M 61.21M 56.51M 52.71M 99.31M 6.61B 101M 678M 263M 3.26B 263M 257M 11.37B
Net Debt - -
Logo Seegene, Inc.
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.
Employees
216
Date Price Change Volume
26-06-30 ₩29,700.00 -2.46% 217,379
26-06-29 ₩30,450.00 +8.75% 399,845
26-06-26 ₩28,000.00 -3.95% 331,602
26-06-25 ₩29,150.00 +8.16% 449,393
26-06-24 ₩26,950.00 -0.37% 230,629
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
29,700.00KRW
Average target price
39,500.00KRW
Spread / Average Target
+33.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A096530 Stock